Role of an inverted CCAAT element in human topoisomerase IIalpha gene expression in ICRF-187-sensitive and -resistant

S E Morgan1, W T Beck

  • 1Division of Molecular Pharmacology, Departments of Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois 60607, USA.

Molecular Pharmacology
|February 13, 2001
PubMed

Insights

Drug resistance in leukemia involves altered DNA topoisomerase IIalpha (topoIIalpha) gene expression. This study reveals that a specific promoter region, ICE3, negatively regulates topoIIalpha, and its reduced function contributes to drug resistance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Tumor cells resistant to topoisomerase II (topoII) inhibitors often exhibit altered topoIIalpha gene expression.
  • Understanding topoIIalpha transcriptional regulation is crucial for deciphering drug resistance mechanisms.

Purpose of the Study:

  • To investigate the transcriptional regulation of the human DNA topoisomerase IIalpha (topoIIalpha) gene in drug-resistant leukemia cells.
  • To identify specific promoter elements responsible for increased topoIIalpha expression in cells resistant to topoII inhibitors.

Main Methods:

  • Transient transfection assays using luciferase reporter plasmids with human topoIIalpha promoter constructs.
  • Analysis of promoter activity in drug-sensitive (CEM) and drug-resistant (CEM/ICRF-8) human leukemic cell lines.
  • Electrophoretic mobility shift assays (EMSA) to study protein-DNA interactions within the topoIIalpha promoter.

Main Results:

  • TopoIIalpha transcriptional activity was significantly increased (doubled) in drug-resistant CEM/ICRF-8 cells compared to sensitive CEM cells.
  • A key regulatory region responsible for this up-regulation was localized between nucleotides -557 and -162 of the topoIIalpha promoter, encompassing inverted CCAAT elements (ICE) 3 to 5.
  • A point mutation in ICE3 significantly increased promoter activity in drug-sensitive cells, and EMSA indicated reduced binding of an NF-YB containing complex to ICE3 in resistant cells, suggesting negative regulation by ICE3.

Conclusions:

  • Transcriptional up-regulation of topoIIalpha in ICRF-187-resistant cells is partly mediated by altered regulation of the third inverted CCAAT box (ICE3) in the topoIIalpha promoter.
  • ICE3 appears to function as a negative regulatory element in human topoIIalpha gene expression, and its diminished regulatory capacity contributes to increased topoIIalpha levels in resistant cells.

Related Concept Videos

DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...